erectile%20dysfunction
ERECTILE DYSFUNCTION

Erectile dysfunction is the inability to attain and maintain an erection enough to have satisfactory sexual performance for ≥3 months.

It is when the patient complains of partial erection that could not attain vaginal penetration.

Complete loss of penile rigidity is uncommon.

Initial penile erections can penetrate but early detumescence occurs without ejaculation.

Surgical Intervention

Penile Vascular Surgery

  • Arterial reconstructive surgery should be considered only in healthy men w/ recently acquired erectile dysfunction due to a focal arterial occlusion in the absence of a generalized vascular disease

Penile Drug Delivery (Implanted) Devices

  • May be tried before standard implants are used if erection is possible w/ pharmacological injection

Penile Implants

  • Considered final treatment for erectile dysfunction patients & should be reserved for patients who have failed other treatments
  • Irreversible & highly invasive
  • When performed by experienced surgeon has been associated w/ high rate of patient satisfaction
  • May have surgical complication & mechanical failure
  • Available classes of penile implants are inflatable (2- & 3- piece) & malleable devices
  • Surgical approaches include penoscrotal & infrapubic
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
09 Jan 2020
Acute ischaemic stroke patients who are current or recent smokers are at greater odds of having unfavourable functional outcomes 3 months after the index event, a study has found.
Stephen Padilla, 2 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.
3 days ago
Anaemia increases mortality risk in heart failure (HF) patients across the ejection fraction (EF) spectrum, a recent study has found. The effect appears to be stronger in preserved (HFpEF) and midrange (HFmrEF) than in reduced (HFrEF) EF disease.